Evidence map›Paper›PMID 36906646›Full record

ReviewInternational ophthalmology2023

Assessment of corneal endothelial cell parameters using specular microscopy in previously infected SARS-CoV-2 patients.

Mohamed Anis Elshalkami, Tarek Mohamed Mahmoud Abdalla, Mona Kamal Abdellatif, Samah Mahmoud Fawzy

Open access · bronzeAbstract readReview
In one paragraph

Review in International ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mohamed Anis ElshalkamiDepartment of Ophthalmology, Ain Shams University Hospitals, Ramses St., Abbasiya, Cairo, 11517, Egypt. drmohamedanis@gmail.com.ORCID http://orcid.org/0000-0003-2302-7137
Tarek Mohamed Mahmoud AbdallaDepartment of Ophthalmology, Ain Shams University Hospitals, Ramses St., Abbasiya, Cairo, 11517, Egypt.
Mona Kamal AbdellatifDepartment of Ophthalmology, Ain Shams University Hospitals, Ramses St., Abbasiya, Cairo, 11517, Egypt.
Samah Mahmoud FawzyDepartment of Ophthalmology, Ain Shams University Hospitals, Ramses St., Abbasiya, Cairo, 11517, Egypt.
Ain Shams University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo examine the long-term effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the corneal endothelium.

methodsThis was a comparative, cross-sectional study that included subjects who had recovered from SARS-CoV-2 infection for at least 6 months (group 1) and a group of age- and sex-matched controls with no prior symptomatology or documentation of SARS-CoV-2 infection (group 2). After full ophthalmological evaluation, specular microscopy was used to examine the endothelial cell parameters, including endothelial cell density, coefficient of variation, hexagonality, average area, and central corneal thickness.

resultsSixty-four and 53 right eyes were included in groups 1 and 2, respectively. No statistically significant differences were detected in any of the examined specular parameters between the two groups.

conclusionSARS-CoV-2 infection may have no delayed sequel on the corneal endothelium. Future prospective studies with repeated examinations in the same subjects would be useful.

Indexed as

COVID-19SARS-CoV-2Cell CountCross-Sectional StudiesEndothelial CellsEndothelium, CornealHumansMicroscopyProspective StudiesCorneal endotheliumCoronavirus disease 2019COVID-19SARS-CoV-2Specular microscopy

Identifiers

PMID36906646
PMCPMC10008069
OpenAlexW4323929087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.